# Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

> **NCT01525602** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 74 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** PLX3397
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01525602
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2017-12
- **Final completion:** 2018-02
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01525602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01525602, "Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01525602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*